Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00899912 · ClinicalTrials.gov registry record
Changes in DNA After Radiation Therapy in Patients With Prostate Cancer
A clinical trial, sponsored by Radiation Therapy Oncology Group.
- Completed
- Registry status
- 13
- Enrollment target
NCT00899912: Completed study, sponsored by Radiation Therapy Oncology Group.
NCT00899912 is a clinical trial that has completed, run by Radiation Therapy Oncology Group. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00899912 has completed, sponsored by Radiation Therapy Oncology Group.
- COMPLETED
- Registry status
- 13 participants
- Enrollment target
Study Summary
RATIONALE: Collecting and storing samples of tissue from patients with cancer to study in the laboratory may help doctors learn more about changes that may occur in DNA after radiation therapy and identify biomarkers related to cancer. PURPOSE: This laboratory study is looking at changes in DNA after radiation therapy in patients with prostate cancer.
Interventions
- GENETIC microarray analysis
- OTHER diagnostic laboratory biomarker analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2006-06 |
| Est. Completion | 2013-11 |
What the finished NCT00899912 record still lists
NCT00899912 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 13 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which microarray analysis is the first listed.
NCT00899912 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00899912 about?
NCT00899912 is a clinical study titled "Changes in DNA After Radiation Therapy in Patients With Prostate Cancer". RATIONALE: Collecting and storing samples of tissue from patients with cancer to study in the laboratory may help doctors learn more about changes that may occur in DNA after radiation therapy and identify biomarkers related to cancer. PURPOSE: This laboratory study is looking at changes in DNA aft...
What is the current status of trial NCT00899912?
This trial is currently completed. The enrollment target is 13 participants. The study started on 2006-06. Estimated completion is 2013-11.
What interventions are being tested in trial NCT00899912?
The interventions under investigation include: microarray analysis (GENETIC), diagnostic laboratory biomarker analysis (OTHER).
Who is sponsoring clinical trial NCT00899912?
This trial is sponsored by Radiation Therapy Oncology Group, which has 144 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia